Tumor metastasis, which accounts for the majority of deaths in breast cancer patients, is a process by which cancer cells acquire the ability to invade tissue and survive in other parts of the body.
Dysregulation of the protein TGF-β is known to drive breast cancer metastasis, but the precise molecular mechanisms are unknown. In the Journal of Clinical Investigation, researchers led by William Shiemann at Case Western Reserve University identified a microRNA, miR-181a, that is altered by TGF-β to promote metastasis.